comparemela.com

Bank of America lowered shares of Exscientia (NASDAQ:EXAI – Free Report) from a buy rating to a neutral rating in a research report released on Friday morning, Marketbeat.com reports. Bank of America currently has $9.00 price objective on the stock, down from their previous price objective of $11.00. Other research analysts have also issued research […]

Related Keywords

United States ,America , ,Baillie Gifford Co ,Marshall Wace ,Softbank Group ,Platinum Investment Management Ltd ,Barclays ,Morgan Stanley ,Free Report ,Get Free Report ,Investment Management ,Capital Management ,Exscientia Daily ,Exscientia ,Nasdaq Exai ,Exai ,Medical ,Downgrade ,Bank Of America Co ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.